Sulpiride

Amber

Brand Name(s):

Indication:Antipsychotic – patients NOT on the SMI register

Rationale:1,2

Considered:Oct-19

Review Date:Oct-24

Comments:
NICE CG178
Psychosis and schizophrenia in adults: treatment and management
Feb 2014
…………………………
Psychosis and schizophrenia in children and young people
NICE CG 185 Assessment & Management of bipolar disorder
…………………………
National Clinical Guideline Number CG155
January 2013
…………………………
Antipsychotic use may be associated with an increased risk of VTE. At present there are insufficient data available to determine any difference in risk between atypical and conventional antipsychotics, or between individual drugs. All possible risk factors for VTE should be identified before and during antipsychotic treatment and preventive measures undertaken

MHRA Drug safety update Volume 2 Issue 11 June 2009